flu strain — The emergence of a new flu strain, A(H3N2) K, is causing alarm among health specialists due to its rapid mutations and increasing transmissibility. Early epidemiological data from the United Kingdom (UK) indicate a spike in cases, with the flu season commencing earlier than expected this year. Traditionally, flu activity peaks later in the year, but by October, health officials noted a concerning rise in infections.
The influenza virus is known for its ability to evolve, which necessitates annual adjustments to the flu vaccine. However, the K sub-type has reportedly accumulated a significant number of mutations in a short timeframe. Jamie Lopez Bernal, an epidemiologist at the UK Health Security Agency (UKHSA), commented, “This variant (the K) has evolved a bit faster, with more changes than we typically see,” highlighting the strain’s potential impact.
Across Europe, the implications of the new strain are being closely monitored. In Greece, Christos Chatzichristodoulou, President of the National Public Health Organisation (EODY), noted that early data from the UK suggests the K-clade of A(H3N2) is becoming dominant, raising concerns about its transmissibility. National Flu Reference Centres in Greece are currently investigating the potential circulation of this variant.
The A(H3N2) K strain has also been reported in Japan, where health authorities have declared an epidemic. Its mutations are distinct from the strain included in this year’s updated vaccines, prompting scientists in Canada to advocate for vigilant monitoring and more frequent genetic sequencing to evaluate vaccine effectiveness.
Despite the emergence of this new variant, preliminary data released by the UKHSA on 12 November indicates that vaccination still offers robust protection against severe illness and hospitalisation. However, experts caution that the level of protection appears to be slightly lower than typically observed at the end of the flu season, when vaccine efficacy usually declines.
The potential ramifications of this situation for the current flu season remain uncertain. Lopez Bernal remarked, “Influenza is notoriously unpredictable, so it’s very difficult to say what will happen,” suggesting that the combination of early activity and the emergence of a concerning variant raises the likelihood of a more intense flu season. Dr Antonia Ho, an infectious disease specialist at the University of Glasgow, noted that early flu seasons often result in a higher number of illnesses, particularly among the elderly, who are typically more severely affected by H3N2-type strains.
In the United States, data on the flu’s progression is limited due to a recent government shutdown that delayed updates to the CDC surveillance system. However, a report from New York State indicated a staggering 49% increase in cases within a week, alongside a 71% rise in hospitalisations, although it remains unclear if the K strain has reached the US.
